Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2 CAD | -4.76% | -0.99% | -25.93% |
04-17 | NervGen Reports FY 2023 Net Loss of $0.38 Per Share, Provides Operations Update | MT |
04-17 | NervGen Pharma Corp. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |